BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 5, 2002
View Archived Issues
Efficacy of rosiglitazone in ameliorating acute and chronic colitis
Read More
BIRB-796BS investigated in humans for safety, pharmacokinetics and pharmacodynamics
Read More
Alefacept is nonimmunogenic according to prospective analysis of phase III data
Read More
Inhibition of IL-8 appears to be involved in the cardioprotective mechanism of FR-183998
Read More
Comparison of safety and efficacy of three drugs for the treatment of obesity
Read More
FDA approves Remicade for improvement of physical function in RA
Read More
Shire summarizes quarter's R&D highlights
Read More
Effects of rhuIL-4R on antigen-specific T-cells may contribute to its clinical efficacy
Read More
Dosing will not resume in study of AN-1792 in Alzheimer's disease
Read More
FDA accepts Zetia NDA filing for hypercholesterolemia
Read More
Connetics' sNDA for Olux accepted by FDA
Read More
FDA finds Imavist approvable in echocardiography
Read More
AAAAI news: potential beneficial effects of Flt3 ligand in asthma
Read More
Third dendritic cell-based immunotherapy from Northwest Biotherapeutics cleared for clinical trials
Read More
Novartis prepares and tests PARP inhibitors
Read More
Compounds inhibiting the production of IL-2 in T-lymphocytes patented by Boehringer Ingelheim
Read More
Agonists of group I metabotropic glutamate receptors prepared by Roche
Read More
Roche reports antagonists of group I mglu receptors with potential in epilepsy, etc.
Read More
New patent covers compounds for conditions associated with undesirable bone resorption
Read More
Servier identifies compounds with potential in cognitive disorders
Read More
Beta3-adrenoceptor agonists claimed for the treatment of obesity and type 2 diabetes
Read More
Macrocyclic compounds useful as contrast agents for magnetic resonance imaging
Read More
Ridogrel has no significant efficacy in the treatment of ulcerative colitis
Read More
Limited activity of BMS-182751 as a treatment for recurrent cervical cancer
Read More
